Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Actavis plc | 263,729 | reported | 02 May 2018 | tx 31+692,234−298,773 |
| BARR PHARMACEUTICALS INC | 133,077 | reported | 23 Oct 2007 | tx 128+791,657−1,077,053 |
| MYRIAD GENETICS INC | 97,441 | reported | 14 May 2026 | tx 5+97,441 |
| Amneal Pharmaceuticals, Inc. | 74,950 | reported | 07 May 2019 | tx 9+1,663,023−37,512 |
| Keenova Therapeutics plc | 47,225 | reported | 23 Feb 2026 | tx 19+160,098−144,234 |
| Zoetis Inc. | 27,862 | reported | 13 May 2026 | tx 35+55,184−25,866.41 |
| CROFF ENTERPRISES INC | 5,000 | reported | 29 Sept 2022 | tx 9+399,886−98,848 |
| ZIMMER BIOMET HOLDINGS, INC. | 3,095.29 | reported | 31 Mar 2017 | tx 20+6,569.6 |
| WATSON PHARMACEUTICALS INC | 0 | reported | 01 Oct 2013 | tx 27+1,611,492−1,611,492 |
| IMPAX LABORATORIES INC | 0 | reported | 04 May 2018 | tx 2+850,000−850,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | PURCHASE | MYRIAD GENETICS INC | 7,500 | 3.69 USD | |
| 13 May 2026 | PURCHASE | Zoetis Inc. | 2,000 | 75.88 USD | first after silence |
| 23 Feb 2026 | GRANT_AWARD | Keenova Therapeutics plc | 3,984 | 0.00 USD | deriv |
| 19 Feb 2026 | EXERCISE | Zoetis Inc. | 1,619 | — | |
| 19 Feb 2026 | EXERCISE | Zoetis Inc. | 1,619.33 | — | deriv |
| 18 Feb 2026 | GRANT_AWARD | Zoetis Inc. | 1,936 | 0.00 USD | deriv |
| 01 Jan 2026 | EXERCISE | Keenova Therapeutics plc | 3,014 | — | |
| 01 Jan 2026 | TAX_WITHHOLDING | Keenova Therapeutics plc | 854 | — | |
| 01 Jan 2026 | OTHER | Keenova Therapeutics plc | 2,466 | — | deriv |
| 01 Jan 2026 | EXERCISE | Keenova Therapeutics plc | 3,014 | 0.00 USD | deriv |
| 14 Aug 2025 | GRANT_AWARD | Keenova Therapeutics plc | 4,062 | 0.00 USD | deriv |
| 31 Jul 2025 | GRANT_AWARD | Keenova Therapeutics plc | 27,357 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | MYRIAD GENETICS INC | 49,796 | 0.00 USD | |
| 19 Feb 2025 | GRANT_AWARD | Zoetis Inc. | 1,596 | 0.00 USD | deriv |
| 08 Feb 2025 | EXERCISE | Zoetis Inc. | 1,225 | — | |
| 08 Feb 2025 | EXERCISE | Zoetis Inc. | 1,225.4 | — | deriv |
| 06 Feb 2025 | EXERCISE | Zoetis Inc. | 1,236 | — | |
| 06 Feb 2025 | EXERCISE | Zoetis Inc. | 1,236.21 | — | deriv |
| 01 Jan 2025 | EXERCISE | Keenova Therapeutics plc | 2,507 | — | |
| 01 Jan 2025 | TAX_WITHHOLDING | Keenova Therapeutics plc | 489 | — | |
| 01 Jan 2025 | EXERCISE | Keenova Therapeutics plc | 2,507 | 0.00 USD | deriv |
| 01 Jan 2025 | OTHER | Keenova Therapeutics plc | 2,052 | — | deriv |
| 06 Jun 2024 | GRANT_AWARD | MYRIAD GENETICS INC | 15,695 | 0.00 USD | |
| 19 Feb 2024 | GRANT_AWARD | Keenova Therapeutics plc | 13,678 | 0.00 USD | deriv |
| 10 Feb 2024 | EXERCISE | Zoetis Inc. | 1,463 | — |
5 purchases reported after at least 12 months of silence — most recent on 13 May 2026.